![ASCO 2018: GamaMabs Pharma to present results from the First-In-Human clinical study of GM102 in gynecological cancers](https://ala.associates/wp-content/uploads/2017/10/SDegove-1080x675.jpg)
![ASCO 2018: GamaMabs Pharma to present results from the First-In-Human clinical study of GM102 in gynecological cancers](https://ala.associates/wp-content/uploads/2017/10/SDegove-1080x675.jpg)
![Robocath demonstrates safety and efficacy of its R-OneTM medical robotic platform](https://ala.associates/wp-content/uploads/2018/05/MG_1610-BDEF-1080x675.jpg)
Robocath demonstrates safety and efficacy of its R-OneTM medical robotic platform
![ASCO 2018: GamaMabs Pharma to present results from the First-In-Human clinical study of GM102 in gynecological cancers](https://ala.associates/wp-content/uploads/2017/10/SDegove-1080x675.jpg)
GamaMabs Pharma to present new data at AACR 2018
![Genoscience Pharma starts first-in-human dosing of GNS561 in patients with advanced liver cancer](https://ala.associates/wp-content/uploads/2018/04/HALFONPhilippe.png)
Genoscience Pharma starts first-in-human dosing of GNS561 in patients with advanced liver cancer
![SafeHeal starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy](https://ala.associates/wp-content/uploads/2018/01/Colovac-Product.jpg)
SafeHeal starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy
![Minoryx Therapeutics announces the dosing of first patient in ADVANCE](https://ala.associates/wp-content/uploads/2017/02/Photo-Marc-Martinell-2015-1080x675.jpg)
Minoryx Therapeutics announces the dosing of first patient in ADVANCE
![Imcyse continues patient enrolment in its Phase 1b trial in type 1 diabetes](https://ala.associates/wp-content/uploads/2017/11/Visit-DK-site-Oct-20172-copy-e1513079031649-1080x607.jpg)
Imcyse continues patient enrolment in its Phase 1b trial in type 1 diabetes
![Aelix Therapeutics enrolls first patient in company’s initial therapeutic HIV vaccine clinical trial](https://ala.associates/wp-content/uploads/2017/09/jose-luis-cabero.png)
Aelix Therapeutics enrolls first patient in company’s initial therapeutic HIV vaccine clinical trial
![Prexton announces initiation of phase II clinical testing in Parkinson’s disease](https://ala.associates/wp-content/uploads/2017/02/CONQUET-Francois-e1486458395645-1080x675.jpg)
Prexton announces initiation of phase II clinical testing in Parkinson’s disease
![Lung cancer: Vaxon announces results of its Vx-001 therapeutic vaccine Phase IIb trial](https://ala.associates/wp-content/uploads/2017/06/K-Kosmatopoulos-1080x675.jpg)